Inspire Medical (INSP) Director Michael Carrel Receives RSU Award

What Happened

• Michael H. Carrel, a director of Inspire Medical Systems (INSP), was granted 5,631 restricted stock units (RSUs) on July 20, 2026. The award is recorded at $0.00 per unit (no cash purchase); total recorded consideration = $0.
• This is a compensation award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-20; Filing date (Form 4): 2026-07-27 (appears to be filed after the typical 2-business-day Form 4 window).
• Grant: 5,631 RSUs @ $0.00 per RSU (reported acquisition amount $0).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: F1 — Each RSU is a contingent right to one share of common stock. RSUs vest in three equal annual installments on the first three anniversaries of the grant date, subject to continued board service through each vesting date.
• Transaction type: Award/Grant (A). No 10b5-1 plan, tax withholding, or cashless sale reported in the provided details.

Context

• RSU grants are a form of compensation for directors/executives and typically vest over time; they do not represent an immediate cash investment or sale.
• Such grants are standard corporate compensation and, by themselves, are not a clear buy/sell signal. The filing appears late relative to the usual Form 4 deadline, which can matter to investors tracking timely insider activity.